Anti-B3GALT4 antibody [EPR11650]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal B3GALT4 antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 4 publications.
View Alternative Names
GALT4, B3GALT4, Beta3Gal-T4, Beta3GalT4, GalT4, b3Gal-T4, Gal-T2, Ganglioside galactosyltransferase
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-B3GALT4 antibody [EPR11650] (AB169759)
Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labeling B3GALT4 with ab169759 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-B3GALT4 antibody [EPR11650] (AB169759)
Immunohistochemical analysis of paraffin-embedded Human muscle tissue labeling B3GALT4 with ab169759 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-B3GALT4 antibody [EPR11650] (AB169759)
All lanes:
Western blot - Anti-B3GALT4 antibody [EPR11650] (ab169759) at 1/10000 dilution
Lane 1:
Fetal tissue lysate at 10 µg
Lane 2:
PC-3 cell lysate at 10 µg
Lane 3:
Jurkat cell lysate at 10 µg
Lane 4:
U87-MG cell lysate at 10 µg
Predicted band size: 42 kDa
false
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-B3GALT4 antibody [EPR11650] (AB169759)
Intracellular flow cytometric analysis of permeabilized Jurkat cells labeling B3GALT4 with ab169759 at 1/10 dilution (red) or a rabbit IgG (negative) (green).
Related conjugates and formulations (1)
-
Anti-B3GALT4 antibody [EPR11650] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme B3GALT4 contributes to the synthesis of glycan structures. It participates in the glycosphingolipid biosynthesis pathway where it has involvement in the addition of galactose to lactosylceramide. By doing so B3GALT4 helps in transforming lactosylceramide into more complex glycolipids which are components of cell membranes and mediate cell-cell interactions. This enzyme is not known as part of a larger complex but it acts independently within the glycosylation machinery.
Pathways
B3GALT4 functions within the glycosphingolipid metabolism and the N-glycan biosynthesis pathways. It contributes to the complexity and diversity of glycan structures that are key in these pathways. B3GALT4 interacts with other glycosyltransferases such as beta-14-galactosyltransferase in orchestrating the stepwise extension of oligosaccharide chains. Understanding these pathways offers insight into how B3GALT4 contributes to essential cellular functions like cell signaling and immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
PLoS biology 23:e3003362 PubMed40934285
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 15:488 PubMed39331217
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 13:1061814 PubMed36605200
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 18:637-651 PubMed35002514
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com